Common Contracts
2 similar Underwriting Agreement contracts by RedHill Biopharma Ltd., Tandem Diabetes Care Inc
and Series A Warrants to Purchase up to 4,630,000 Shares of Common Stock Series B Warrants to Purchase up to 4,630,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 13th, 2017 • Tandem Diabetes Care Inc • Surgical & medical instruments & apparatus • New York
Tandem Diabetes Care, Inc., a Delaware corporation (the "Company"), confirms its agreement with Oppenheimer & Co. Inc. ("Oppenheimer") and each of the other Underwriters named in Schedule A hereto (collectively, the "Underwriters," which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Oppenheimer is acting as representative (in such capacity, the "Representative"), with respect to the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of (x) shares (the "Shares") of Common Stock, par value $0.001 per share, of the Company ("Common Stock") set forth in Schedule A hereto, (y) Series A warrants to purchase up to an aggregate of 4,630,000 shares of Common Stock (the "Series A Warrants") and (z) Series B warrants to purchase up to an aggregate of 4,630,000 shares of Common Stock (the "Series B Warrants" and together with the Series A Warrants, the "Warrants") set fo
REDHILL BIOPHARMA LTD. 2,462,000 American Depositary Shares UNDERWRITING AGREEMENT Dated: July 16, 2015Underwriting Agreement • July 21st, 2015 • RedHill Biopharma Ltd. • Pharmaceutical preparations • New York
Nomura Securities International, Inc. As Representative of the several Underwriters c/o Nomura Securities International, Inc. 309 West 48th Street New York, New York 10019
